𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absolute stereochemistry of 2-hydroxyglutaric acid present in methanopterin

✍ Scribed by Barbara Thurston Solow; Robert H. White


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
51 KB
Volume
9
Category
Article
ISSN
0899-0042

No coin nor oath required. For personal study only.

✦ Synopsis


The absolute stereochemistry of the 2-hydroxyglutaric acid present in methanopterin and its ␣-glutamyl derivative, sarcinapterin, has been determined to be (S). Thus, the absolute stereochemistry of the 2-hydroxyglutaric acid present in the side chain of these modified folates is the same as the L-glutamic acid present in the side chain of folates.


πŸ“œ SIMILAR VOLUMES


Induction of oxidative stress by L-2-hyd
✍ Alexandra Latini; Karina Scussiato; Rafael Borba Rosa; Guilhian Leipnitz; Susana πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## Abstract L‐2‐hydroxyglutaric acid (LGA) is the biochemical hallmark of L‐2‐hydroxyglutaric aciduria (L‐OHGA), an inherited neurometabolic disorder characterized by progressive neurodegeneration with cerebellar and pyramidal signs, mental deterioration, epilepsy, and subcortical leukoencephalopat

Excitatory amino acid receptor antagonis
✍ Tommy N. Johansen; Karla Frydenvang; Bjarke Ebert; Ulf Madsen; Povl Krogsgaard-L πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 228 KB πŸ‘ 2 views

We have previously shown that (RS)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA) is an antagonist at N-methyl-D-aspartic acid (NMDA) and (RS)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptors. We have now resolved ATAA via diastereomeric salt formation us

Resolution, absolute stereochemistry, an
✍ Eva H. MΓΈller; Jan Egebjerg; Lotte Brehm; Tine B. StensbΓΈl; Tommy N. Johansen; U πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

The phosphono amino acid, (RS)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO), is a structural hybrid between the NMDA antagonist (RS)-2-amino-7-phosphonoheptanoic acid (AP7) and the AMPA and GluR5 agonist, (RS)-2-amino-3-(5-tert-butyl-3-hydroxy-4-isoxazolyl)propioni